Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
J Biol Chem ; 292(46): 18821-18830, 2017 11 17.
Article in English | MEDLINE | ID: mdl-28935669

ABSTRACT

The nuclear factor κB (NF-κB) transcription factor family regulates genes involved in cell proliferation and inflammation. The promoters of these genes often contain NF-κB-binding sites (κB sites) arranged in tandem. How NF-κB activates transcription through these multiple sites is incompletely understood. We report here an X-ray crystal structure of homodimers comprising the RelA DNA-binding domain containing the Rel homology region (RHR) in NF-κB bound to an E-selectin promoter fragment with tandem κB sites. This structure revealed that two dimers bind asymmetrically to the symmetrically arranged κB sites at which multiple cognate contacts between one dimer to the corresponding DNA are broken. Because simultaneous RelA-RHR dimer binding to tandem sites in solution was anti-cooperative, we inferred that asymmetric RelA-RHR binding with fewer contacts likely indicates a dissociative binding mode. We found that both κB sites are essential for reporter gene activation by full-length RelA homodimer, suggesting that dimers facilitate DNA binding to each other even though their stable co-occupation is not promoted. Promoter variants with altered spacing and orientation of tandem κB sites displayed unexpected reporter activities that were not explained by the solution-binding pattern of RelA-RHR. Remarkably, full-length RelA bound all DNAs with a weaker affinity and specificity. Moreover, the transactivation domain played a negative role in DNA binding. These observations suggest that other nuclear factors influence full-length RelA binding to DNA by neutralizing the transactivation domain negative effect. We propose that DNA binding by NF-κB dimers is highly complex and modulated by facilitated association-dissociation processes.


Subject(s)
DNA/metabolism , E-Selectin/genetics , Promoter Regions, Genetic , Transcription Factor RelA/metabolism , Transcriptional Activation , Animals , Base Sequence , Binding Sites , Crystallography, X-Ray , DNA/genetics , Gene Expression Regulation , Mice , Models, Molecular , Protein Binding , Protein Domains , Protein Multimerization , Transcription Factor RelA/chemistry
2.
Nucleic Acids Res ; 41(18): 8637-53, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23892287

ABSTRACT

Structural and biochemical studies have demonstrated that p73, p63 and p53 recognize DNA with identical amino acids and similar binding affinity. Here, measuring transactivation activity for a large number of response elements (REs) in yeast and human cell lines, we show that p53 family proteins also have overlapping transactivation profiles. We identified mutations at conserved amino acids of loops L1 and L3 in the DNA-binding domain that tune the transactivation potential nearly equally in p73, p63 and p53. For example, the mutant S139F in p73 has higher transactivation potential towards selected REs, enhanced DNA-binding cooperativity in vitro and a flexible loop L1 as seen in the crystal structure of the protein-DNA complex. By studying, how variations in the RE sequence affect transactivation specificity, we discovered a RE-transactivation code that predicts enhanced transactivation; this correlation is stronger for promoters of genes associated with apoptosis.


Subject(s)
DNA-Binding Proteins/chemistry , Nuclear Proteins/chemistry , Response Elements , Trans-Activators/chemistry , Transcriptional Activation , Tumor Suppressor Protein p53/chemistry , Tumor Suppressor Proteins/chemistry , Alleles , Base Sequence , Cell Line, Tumor , Consensus Sequence , DNA/chemistry , DNA/metabolism , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Humans , Mutation , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Phenotype , Phenylalanine/chemistry , Protein Structure, Tertiary , Purines/analysis , Pyrimidines/analysis , Saccharomyces cerevisiae/genetics , Sequence Analysis, DNA , Trans-Activators/genetics , Trans-Activators/metabolism , Tumor Protein p73 , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism , Tumor Suppressor Proteins/genetics , Tumor Suppressor Proteins/metabolism
3.
J Biol Chem ; 288(7): 4744-54, 2013 Feb 15.
Article in English | MEDLINE | ID: mdl-23243311

ABSTRACT

How cells choose between developmental pathways remains a fundamental biological question. In the case of the p53 protein family, its three transcription factors (p73, p63, and p53) each trigger a gene expression pattern that leads to specific cellular pathways. At the same time, these transcription factors recognize the same response element (RE) consensus sequences, and their transactivation of target genes overlaps. We aimed to understand target gene selectivity at the molecular level by determining the crystal structures of the p73 DNA-binding domain (DBD) in complex with full-site REs that vary in sequence. We report two structures of the p73 DBD bound as a tetramer to 20-bp full-site REs based on two distinct quarter-sites: GAACA and GAACC. Our study confirms that the DNA-binding residues are conserved within the p53 family, whereas the dimerization and tetramerization interfaces diverge. Moreover, a conserved lysine residue in loop L1 of the DBD senses the presence of guanines in positions 2 and 3 of the quarter-site RE, whereas a conserved arginine in loop 3 adapts to changes in position 5. Sequence variations in the RE elicit a p73 conformational response that might explain target gene specificity.


Subject(s)
DNA-Binding Proteins/chemistry , Nuclear Proteins/chemistry , Transcription Factors/chemistry , Tumor Suppressor Protein p53/chemistry , Tumor Suppressor Proteins/chemistry , Amino Acid Sequence , Anisotropy , Binding Sites , Crystallography, X-Ray/methods , DNA/chemistry , Dimerization , Humans , Molecular Conformation , Molecular Sequence Data , Protein Binding , Protein Conformation , Protein Structure, Tertiary , Response Elements , Sequence Homology, Amino Acid , Transcriptional Activation , Tumor Protein p73
SELECTION OF CITATIONS
SEARCH DETAIL